1. Johnson, Gavin S, Rajendran, Praveen, Dashwood, Roderick H. 2020. CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis. In Cancer science, 111, 3416-3425. doi:10.1111/cas.14579. https://pubmed.ncbi.nlm.nih.gov/33403784/
2. Wang, Yuhao, Wang, Meng, Chen, Jiaxin, Song, Zhangfa, Hooper, Lora V. 2023. The gut microbiota reprograms intestinal lipid metabolism through long noncoding RNA Snhg9. In Science (New York, N.Y.), 381, 851-857. doi:10.1126/science.ade0522. https://pubmed.ncbi.nlm.nih.gov/37616368/
3. Karasu, Mehmet E, Jahnke, Leonard, Joseph, Brian J, Jonas, Stefanie, Corn, Jacob E. 2024. CCAR1 promotes DNA repair via alternative splicing. In Molecular cell, 84, 2634-2647.e9. doi:10.1016/j.molcel.2024.06.011. https://pubmed.ncbi.nlm.nih.gov/38964321/
4. Hu, Zongqiang, Chen, Gang, Zhao, Yingpeng, Ran, Jianghua, Li, Li. 2023. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. In Molecular cancer, 22, 55. doi:10.1186/s12943-023-01759-1. https://pubmed.ncbi.nlm.nih.gov/36932387/
5. Harada, Naoya, Asada, Shuhei, Jiang, Lige, Iyer, Divya R, D'Andrea, Alan D. 2024. The splicing factor CCAR1 regulates the Fanconi anemia/BRCA pathway. In Molecular cell, 84, 2618-2633.e10. doi:10.1016/j.molcel.2024.06.031. https://pubmed.ncbi.nlm.nih.gov/39025073/
6. Fiorentino, David, Mecoli, Christopher A, Igusa, Tak, Christopher-Stine, Lisa, Casciola-Rosen, Livia. 2023. Association of Anti-CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti-Transcriptional Intermediary Factor 1γ-Positive Dermatomyositis. In Arthritis & rheumatology (Hoboken, N.J.), 75, 1238-1245. doi:10.1002/art.42474. https://pubmed.ncbi.nlm.nih.gov/36762496/
智鼠故事 
